Messer covers the Healthcare sector, focusing on stocks such as Phasebio Pharmaceuticals, Aeglea Biotherapeutics, and Ionis Pharmaceuticals. NextCure has an analyst consensus of Strong Buy, with a …
NextCure (NXTC) Gets a Buy Rating from Needham
NextCure (NXTC) Gets a Buy Rating from Needham
Leave a reply